Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug 21;3(3):464-83.
doi: 10.3390/microorganisms3030464.

Role of Bacterial Exopolysaccharides as Agents in Counteracting Immune Disorders Induced by Herpes Virus

Affiliations
Review

Role of Bacterial Exopolysaccharides as Agents in Counteracting Immune Disorders Induced by Herpes Virus

Concetta Gugliandolo et al. Microorganisms. .

Abstract

Extreme marine environments, such as the submarine shallow vents of the Eolian Islands (Italy), offer an almost unexplored source of microorganisms producing unexploited and promising biomolecules for pharmaceutical applications. Thermophilic and thermotolerant bacilli isolated from Eolian vents are able to produce exopolysaccharides (EPSs) with antiviral and immunomodulatory effects against Herpes simplex virus type 2 (HSV-2). HSV-2 is responsible for the most common and continuously increasing viral infections in humans. Due to the appearance of resistance to the available treatments, new biomolecules exhibiting different mechanisms of action could provide novel agents for treating viral infections. The EPSs hinder the HSV-2 replication in human peripheral blood mononuclear cells (PBMC) but not in WISH (Wistar Institute Susan Hayflic) cells line, indicating that cell-mediated immunity was involved in the antiviral activity. High levels of Th1-type cytokines were detected in PBMC treated with all EPSs, while Th2-type cytokines were not induced. These EPSs are water soluble exopolymers able to stimulate the immune response and thus contribute to the antiviral immune defense, acting as immunomodulators. As stimulants of Th1 cell-mediated immunity, they could lead to the development of novel drugs as alternative in the treatment of herpes virus infections, as well as in immunocompromised host.

Keywords: Eolian Islands; antivirals; exopolysaccharides; extremophiles; herpes simplex virus; immunomodulators; shallow marine vents.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Eolian Archipelago (Italy).
Figure 2
Figure 2
Elution profiles from DEAE-Sepharose CL-6B of EPSs fractions produced by Bacillus licheniformis strain B3-15 (a); Geobacillus thermodenitrificans strain B3-72 (b); Bacillus licheniformis strain T14 (c).
Figure 3
Figure 3
GC-MS of hydrolysed EPSs fractions produced by Bacillus licheniformis strain B3-15 (a); Geobacillus thermodenitrificans strain B3-72 (b); Bacillus licheniformis strain T14 (c).
Figure 4
Figure 4
1H-NMR and 13C-NMR spectra of EPSs fractions.
Figure 4
Figure 4
1H-NMR and 13C-NMR spectra of EPSs fractions.
Figure 5
Figure 5
IR spectrum of the EPS1 produced by B. licheniformis strain T14.

References

    1. Maugeri T.L., Bianconi G., Canganella F., Danovaro R., Gugliandolo C., Italiano F., Lentini V., Manini E., Nicolaus B. Shallow hydrothermal vents in the southern Tyrrhenian Sea. Chem. Ecol. 2010;26:285–298. doi: 10.1080/02757541003693250. - DOI
    1. Maugeri T.L., Gugliandolo C., Caccamo D., Stackebrandt E. A polyphasic taxonomic study of thermophilic bacilli from shallow, marine vents. Syst. Appl. Microbiol. 2001;24:451–468. doi: 10.1078/0723-2020-00054. - DOI - PubMed
    1. Maugeri T.L., Lentini V., Gugliandolo C., Italiano F., Cousin S., Stackebrandt E. Bacterial and archaeal populations at two shallow hydrothermal vents of Panarea Island (Eolian Islands, Italy) Extremophiles. 2009;13:199–212. doi: 10.1007/s00792-008-0210-6. - DOI - PubMed
    1. Gugliandolo C., Lentini V., Spanò A., Maugeri T.L. New bacilli from shallow hydrothermal vents of Panarea Island (Italy) and their biotechnological potential. J. Appl. Microbiol. 2012;112:1102–1112. doi: 10.1111/j.1365-2672.2012.05272.x. - DOI - PubMed
    1. Finore I., di Donato P., Mastascusa V., Nicolaus B., Poli A. Fermentation technologies for the optimization of marine microbial exopolysaccharide production. Mar. Drugs. 2014;12:3005–3024. doi: 10.3390/md12053005. - DOI - PMC - PubMed